Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2008-04-29
2008-04-29
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S529000, C514S715000, C424S070100
Reexamination Certificate
active
10899398
ABSTRACT:
Disclosed herein is the cosmetic use, as a desquamating agent, of at least one (dihydro)jasmonic acid derivative of a given formula.Further disclosed herein is a cosmetic method for smoothing the visible and/or tactile irregularities of the skin surface, for example, for smoothing wrinkles and fine lines and/or skin spots and/or smoothing the skin, comprising topically applying, to the skin, a composition comprising, in a physiologically acceptable medium, at least one (dihydro)jasmonic acid derivative and glycerine.Other embodiments disclosed herein are novel (dihydro)jasmonic acid derivatives.
REFERENCES:
patent: 5861532 (1999-01-01), Brown et al.
patent: 7098189 (2006-08-01), Malik
patent: 2002/0034524 (2002-03-01), Poret
patent: 2003/0224024 (2003-12-01), Leveque et al.
patent: 2004/0029839 (2004-02-01), Boulle et al.
patent: 0 585 104 (1994-03-01), None
patent: 1 333 021 (2003-08-01), None
patent: 1 333 022 (2003-08-01), None
patent: 1 353 574 (1974-05-01), None
patent: A S48 064054 (1973-09-01), None
patent: WO 93/10756 (1993-06-01), None
Solomon et. al., Clinics In Dermatology, 1996, 14, 95-99.
Dave R., et. al. Amino Acids, 24, 2003, 245-261.
Patent Abstract from Patent Abstracts of Japan for JP A 2001 031552, published Jul. 24, 2001.
Patent Abstract from Patent Abstracts of Japan for JP A 2001 199832, published Feb. 6, 2001.
Office Action from the Japanese Patent Office for Japanese Patent Application No. 2004-219010 (counterpart to U.S. Appl. No. 10/899,398), dated Dec. 2, 2005.
English language Derwent Abstract of EP 1 333 021 A2, published Aug. 6, 2003.
English language Derwent Abstract of EP 1 333 022 A2, published Aug. 6, 2003.
French Search Report for FR 03 09233 (Priority Application for U.S. Appl. No. 10/899,398) dated May 3, 2004.
Dalko Maria
Neuwels Michel
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Issac Roy P
Jiang Shaojia Anna
L'Oreal S.A.
LandOfFree
Use of at least one (dihydro)jasmonic acid derivative as a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of at least one (dihydro)jasmonic acid derivative as a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of at least one (dihydro)jasmonic acid derivative as a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3915512